| Astrazeneca Pharma India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506820 |
NSE Symbol : ASTRAZEN |
P/E(TTM) : 141.42 |
|
ISIN Demat : INE203A01020 |
Div & Yield% : 0.32 |
EPS(TTM) : 52.40 |
|
Book Value(₹) : 284.77 |
Market Cap(₹Cr) : 18,526.25 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 1,295.53 | 1,002.97 | 805.60 | 813.56 | 831.81 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 1,295.53 | 1,002.97 | 805.60 | 813.56 | 831.81 |
| Other Income | 51.23 | 26.10 | 14.76 | 12.84 | 12.99 |
| Stock Adjustments | 33.77 | 48.86 | -14.47 | -2.95 | 39.21 |
| Total Income | 1,380.53 | 1,077.93 | 805.89 | 823.45 | 884.01 |
| EXPENDITURE : | |||||
| Raw Materials | 628.33 | 408.84 | 297.49 | 292.00 | 344.44 |
| Power and Fuel Cost | 4.87 | 5.54 | 8.10 | 7.37 | 7.72 |
| Other Manufacturing Expenses | 14.38 | 13.79 | 8.05 | 9.11 | 9.04 |
| Selling and Administration Expenses | 234.33 | 185.72 | 145.09 | 129.72 | 157.18 |
| Miscellaneous Expenses | 21.49 | 53.95 | 16.01 | 17.40 | 15.24 |
| Employee Benefit Expenses | 241.45 | 259.10 | 230.21 | 219.54 | 216.70 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 235.68 | 150.99 | 100.94 | 148.31 | 133.69 |
| Interest | 1.20 | 0.63 | 0.95 | 1.09 | 1.14 |
| Gross Profit | 234.48 | 150.36 | 99.99 | 147.22 | 132.55 |
| Depreciation | 14.94 | 16.26 | 16.95 | 20.13 | 18.58 |
| Profit Before Tax | 219.54 | 134.10 | 83.04 | 127.09 | 113.97 |
| Current Tax | 58.93 | 38.30 | 22.63 | 34.83 | 31.51 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | -0.90 | -3.49 | -1.19 | -1.04 | 10.25 |
| Reported Net Profit | 161.51 | 99.29 | 61.60 | 93.30 | 72.21 |
| Extraordinary Items | 12.45 | -26.96 | 2.05 | 1.58 | 0.18 |
| Adjusted Net Profit | 149.06 | 126.25 | 59.55 | 91.72 | 72.03 |
| Adjustment below Net Profit | 1.00 | -2.61 | -1.74 | 3.43 | -5.56 |
| Profit/Loss Balance carried down | 455.64 | 378.96 | 324.10 | 232.37 | 168.22 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 40.00 | 20.00 | 5.00 | 5.00 | 2.50 |
| P & L Balance carried down | 578.15 | 455.64 | 378.96 | 324.10 | 232.37 |
| Dividend | - | - | 5.00 | 5.00 | 2.50 |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 1,200.00 | 800.00 | 500.00 | 100.00 | 50.00 |
| Dividend Per Share(Rs) | 24.00 | 16.00 | 10.00 | 2.00 | 1.00 |
| Earnings Per Share-Unit Curr | 64.60 | 39.72 | 24.64 | 37.32 | 28.88 |
| Earnings Per Share(Adj)-Unit Curr | 64.60 | 39.72 | 24.64 | 37.32 | 28.88 |
| Book Value | 284.77 | 235.48 | 204.56 | 182.47 | 145.78 |
| Book Value(Adj)-Unit Curr | 284.77 | 235.48 | 204.56 | 182.47 | 145.78 |